Clinical Trial Update: A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial by Ono Pharmaceutical evaluating ONO-8539 for acid-induced esophageal hypersensitivity in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• ONO-8539

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Acid Reflux | Phase 1 | Status: COMPLETED